Coming October 2: SITC releases abstract titles with each presenting author’s institution (nearly 1,300 last year). We’ll add them to this guide once they’re out.

Clinical immunotherapy at SITC 2026

Nov 4–8, 2026 Phoenix, AZ ~6k attendees Website

42 organizations at SITC 2026 present work in clinical trials & patient care: 14 universities and research institutes, 11 cancer centres and hospitals, 8 pharma and biotech companies, 8 suppliers and service providers and 1 government or non-profit body. Between them they bring 53 presentations to the program. Most represented: Massachusetts General Hospital (6 on the program), University of Pittsburgh (4 on the program), Stanford University (4 on the program). 35 of them have their own page in this guide. As of Sep 29, 2026.

All 242 organizations at SITC 2026 →

Showing 1–6 of 42 organizations

Organization	SITC 2026 Attendance
Massachusetts General Hospital Boston, MA
massgeneral.org Cancer centres & hospitals Harvard teaching hospital in Boston and home of the Mass General Cancer Center.	Session Thu Nov 5 12:00pm–1:30pm Collaborating with Industry Encanto AB Session Fri Nov 6 1:45pm–3:25pm Mechanisms of irAEs Hall A Clinical 1:50pm–2:10pmDiet and Microbiome Drivers of Immune Related Adverse EventsUniversity of Pittsburgh 2:10pm–2:30pmUnlocking the Specificity of the Autoimmune Response in iRAE’sUCSF 2:30pm–2:50pmClinical Trials for irAEs: Where Do We Go Next?Vanderbilt University Medical Center 2:55pm–3:25pm2 abstract presentations — titles not yet released Talk Sat Nov 7 4:15pm–4:25pm Part of Session 206c: Microbiome and Metabolism Gut Microbiota Metabolite Control of Antitumor CD8 T Cell Trafficking 301A Tumor biology Session Sat Nov 7 3:30pm–4:50pm IO in Low Mutation Burden Cancers Hall A Tumor biology 3:35pm–3:55pmTargeted Therapy + ImmunotherapyJohns Hopkins University 3:55pm–4:15pmFrom the Clinic to the Lab: Investigating Mechanisms of Response and Resistance to Immune Checkpoint TherapyMD Anderson Cancer Center 4:15pm–4:35pmBeyond the Canonical Proteome: Identifying Immunogenic Targets in Ovarian TumorsMayo Clinic 4:35pm–4:50pmAbstract presentation — title not yet released Session Sat Nov 7 3:30pm–4:50pm Microbiome and Metabolism 301A Tumor biology 3:30pm–3:45pmCorrecting the Gut Microbiome Dysbiosis in OncologyCentre hospitalier de l'Université de Montréal (CHUM) 3:45pm–4:00pmToward Metabotherapy for CancerStanford University 4:00pm–4:15pmIntratumoral Bacterial Elements in Brain TumorsMoffitt Cancer Center 4:15pm–4:25pmGut Microbiota Metabolite Control of Antitumor CD8 T Cell TraffickingMassachusetts General Hospital 4:25pm–4:35pmGut Microbiome Function Shapes the Efficacy of Tumor Infiltrating Lymphocyte (TIL) Therapy in MelanomaUniversity of Pittsburgh Talk Sat Nov 7 5:40pm–5:55pm Part of Session 207d: Cellular Therapies Learnings From a CAR-T Driver Into Solid Tumor Halls BC Cell therapy Talk Sun Nov 8 10:45am–11:00am Part of Session 303: COOPERATIVE BINDING: The bi-specific VEGF/PD(L)-1 Inhibitor Approach to cancer immunotherapy: Savior or Pretender? Biology of anti-VEGF treatment Hall A New agents · Tumor biology
University of Pittsburgh Pittsburgh, PA
pitt.edu Universities & research institutes Public research university in Pittsburgh, Pennsylvania.	Session Thu Nov 5 12:00pm–1:30pm Navigating Academia as Junior Faculty (as MD or PhD) Encanto AB Talk Thu Nov 5 3:15pm–3:25pm Part of Session I – Grant Writing Essentials Funding Your Research Through Industry Collaboration Encanto AB Workshop Thu Nov 5 2:30pm–5:05pm Grant Writing Workshop 2:30pm–4:30pmSession I – Grant Writing Essentials 4:05pm–4:30pmThe Importance of the Patient Advocate Perspective in Research and How to Effectively Connect with Advocates 4:30pm–5:00pmSession II – Breakout Sessions 5:00pm–5:05pmClosing Talk Thu Nov 5 4:30pm–5:00pm Part of Session II – Breakout Sessions Breakout Table: Interfacing with Industry (Biotech Grants) Encanto AB Talk Thu Nov 5 4:30pm–5:00pm Part of Session II – Breakout Sessions Breakout Table: Low-preliminary Data Grants (DP5, R21, High Risk/High Reward Grants) Encanto AB Talk Fri Nov 6 1:50pm–2:10pm Part of Session 106d: Mechanisms of irAEs Diet and Microbiome Drivers of Immune Related Adverse Events Hall A Clinical · Tumor biology Session Sat Nov 7 9:35am–11:15am Spatial Biology Halls BC Models & tech 9:40am–10:00amHigh-plex Imaging and Spatial TranscriptomicsUniversity of Queensland 10:00am–10:20amSpatial Biomarkers of Immunotherapy ResponseMD Anderson Cancer Center 10:20am–10:40amComputational Spatial Biology and AI-assisted InterpretationProvidence Genomics 10:40am–11:10am2 abstract presentations — titles not yet released Session Sat Nov 7 11:15am–12:15pm Hot Topic Symposium: External Factors Contributing to Immunotherapy Response Halls BC Tumor biology 11:15am–11:30amPostprandial Metabolism and its Potential to Enhance Immunotherapy ResponsesUniversity of Pittsburgh 11:30am–11:45amThe Role of the Intestinal Microbiome in Cancer ImmunotherapyCity of Hope 11:45am–12:05pmDebate: Pros and Cons on Time of Day and Checkpoint InhibitorsEmory University School of Medicine, Fred Hutchinson Cancer Center Talk Sat Nov 7 11:15am–11:30am Part of Session 203: Hot Topic Symposium: External Factors Contributing to Immunotherapy Response Postprandial Metabolism and its Potential to Enhance Immunotherapy Responses Halls BC Tumor biology Talk Sat Nov 7 4:25pm–4:35pm Part of Session 206c: Microbiome and Metabolism Gut Microbiome Function Shapes the Efficacy of Tumor Infiltrating Lymphocyte (TIL) Therapy in Melanoma 301A Tumor biology · Cell therapy Session Sat Nov 7 3:30pm–4:50pm Microbiome and Metabolism 301A Tumor biology 3:30pm–3:45pmCorrecting the Gut Microbiome Dysbiosis in OncologyCentre hospitalier de l'Université de Montréal (CHUM) 3:45pm–4:00pmToward Metabotherapy for CancerStanford University 4:00pm–4:15pmIntratumoral Bacterial Elements in Brain TumorsMoffitt Cancer Center 4:15pm–4:25pmGut Microbiota Metabolite Control of Antitumor CD8 T Cell TraffickingMassachusetts General Hospital 4:25pm–4:35pmGut Microbiome Function Shapes the Efficacy of Tumor Infiltrating Lymphocyte (TIL) Therapy in MelanomaUniversity of Pittsburgh Plenary Sun Nov 8 9:20am–9:30am Part of Session 301: Presidential Session Expert Disucussant Hall A
Stanford University Stanford, CA
stanford.edu Universities & research institutes Private research university in California, home of Stanford Medicine.	Session Thu Nov 5 12:00pm–1:30pm Collaborating with Industry on Investigator-initiated Clinical Trials Encanto AB Clinical Talk Thu Nov 5 3:25pm–3:35pm Part of Session I – Grant Writing Essentials Assembling a Successful Young Investigator and Career Development Award Application for Foundations Encanto AB Workshop Thu Nov 5 2:30pm–5:05pm Grant Writing Workshop 2:30pm–4:30pmSession I – Grant Writing Essentials 4:05pm–4:30pmThe Importance of the Patient Advocate Perspective in Research and How to Effectively Connect with Advocates 4:30pm–5:00pmSession II – Breakout Sessions 5:00pm–5:05pmClosing Workshop Thu Nov 5 2:30pm–4:30pm Session I – Grant Writing Essentials Encanto AB 2:35pm–2:45pmOverview of NIH GrantsNational Cancer Institute 2:45pm–2:55pmStructuring the Necessary Framework for a Winning GrantWeill Cornell Medicine 2:55pm–3:05pmEffective Grant Proposal Writing and Avoiding Common PitfallsUniversity of Wisconsin-Madison 3:05pm–3:15pmK or F Awards? Finding Your NIH Career Development AwardsUniversity of Pennsylvania 3:15pm–3:25pmFunding Your Research Through Industry CollaborationUniversity of Pittsburgh 3:25pm–3:35pmAssembling a Successful Young Investigator and Career Development Award Application for FoundationsStanford University 3:35pm–3:50pmConsiderations for Using AINational Cancer Institute Talk Thu Nov 5 4:30pm–5:00pm Part of Session II – Breakout Sessions Breakout Table: Grants for Physician Scientists (K08 awards and others) Encanto AB Talk Fri Nov 6 1:50pm–2:10pm Part of Session 106c: Immunosenescence Aging and T-Cell Fitness 301BC Tumor biology Talk Fri Nov 6 1:50pm–2:10pm Part of Session 106a: Combination Therapies Involving Cell Therapy Cytokine Recipes for T cell immunotherapy Halls BC Cell therapy · New agents Talk Sat Nov 7 3:45pm–4:00pm Part of Session 206c: Microbiome and Metabolism Toward Metabotherapy for Cancer 301A Tumor biology
Icahn School of Medicine at Mount Sinai New York, NY
icahn.mssm.edu Universities & research institutes Medical school of the Mount Sinai Health System in New York City.	Session Fri Nov 6 11:30am–12:15pm Clinical Oral Abstract Session Halls BC Clinical 11:30am–12:15pm3 abstract presentations — titles not yet released Session Sat Nov 7 5:20pm–6:40pm AI-driven Protein Design to Enhance Cancer Immunotherapy 301BC AI & data · New agents 5:26pm–5:44pmProtein Design to Improve Cell TherapiesTechnical University of Denmark 5:44pm–6:02pmDesigning protein-based hardwares for human immune systemMassachusetts Institute of Technology 6:02pm–6:20pmT cell phenotype and protein structure-informed discovery of TCRs for cell therapyNational Cancer Institute 6:20pm–6:40pm2 abstract presentations — titles not yet released Talk Sat Nov 7 6:20pm–6:40pm Part of Session 207c: Hot and Cold Tumors Hot and Cold Tumor Debate Hall A Tumor biology Session Sat Nov 7 5:20pm–6:40pm Hot and Cold Tumors Hall A Tumor biology 5:20pm–5:40pmWhat Is Meant By Hot And Cold Tumors?UCLA 5:40pm–6:00pmIdentifying Determinants of Hot and Cold Tumors by AI-Assisted Perturb-MapIcahn School of Medicine at Mount Sinai 6:00pm–6:20pm2 abstract presentations — titles not yet released 6:20pm–6:40pmHot and Cold Tumor DebateUCLA, Icahn School of Medicine at Mount Sinai, Brigham and Women's Hospital Talk Sat Nov 7 5:40pm–6:00pm Part of Session 207c: Hot and Cold Tumors Identifying Determinants of Hot and Cold Tumors by AI-Assisted Perturb-Map Hall A Tumor biology · AI & data Session Sat Nov 7 5:20pm–6:40pm Oral Abstract Session 4 301D 5:20pm–6:35pm5 abstract presentations — titles not yet released
Johns Hopkins University Baltimore, MD
jhu.edu Universities & research institutes Private research university in Baltimore, Maryland.	Workshop Thu Nov 5 12:00pm–1:30pm Early Career Scientist Meet-the-Expert Lunch 12:00pm–1:30pmBioinformatics, Big Data, and AI (Table 1) 12:00pm–1:30pmBioinformatics, Big Data, and AI (Table 2) 12:00pm–1:30pmCareer Paths for Physician Scientists 12:00pm–1:30pmCareers Outside Academia and Industry – Careers in Policy, Advocacy and Non-Profit Organizations 12:00pm–1:30pmCollaborating with Industry 12:00pm–1:30pmCollaborating with Industry on Investigator-initiated Clinical Trials 12:00pm–1:30pmHow to Navigate the Graduate Student to Postdoc Transition 12:00pm–1:30pmHow to Navigate the Postdoc to PI Transition 12:00pm–1:30pmIndustry: Building Your Career in Industry (Big Pharma) 12:00pm–1:30pmIndustry: Building Your Career in Industry (Startup and Midsize Pharma) 12:00pm–1:30pmLeadership Opportunities in Immuno-oncology (Academics and Industry) 12:00pm–1:30pmNavigating Academia as Junior Faculty (as MD or PhD) 12:00pm–1:30pmNon-science Skills Needed to be a Successful Postdoc or PI 12:00pm–1:30pmSetting Up a Successful Biotech (Midsize Pharma and Small Startups) 12:00pm–1:30pmTranslational Research: Human Samples to Lab and Back to the Clinic 12:00pm–1:30pmTranslational Research: Mice to Humans 12:00pm–1:30pmTransitioning from Academia to Industry 12:00pm–1:30pmCareers in Venture Capital and Biotechnology Investing Session Fri Nov 6 3:55pm–5:30pm Cytokine Engineering and Clinical Translation 301BC New agents 4:00pm–4:15pmAnchored Cytokine Therapy for Cancer: Engineering the Next Generation of IOMass Eye and Ear 4:15pm–4:30pmAnchored and Targeted CytokinesNew York University 4:30pm–4:45pmmRNA Based Delivery of CytokinesUniversity of Pennsylvania 4:45pm–5:25pm4 abstract presentations — titles not yet released Talk Sat Nov 7 3:50pm–4:10pm Part of Session 206a: New Avenues in Myeloid Cells Neutrophils Halls BC Tumor biology Talk Sat Nov 7 3:35pm–3:55pm Part of Session 206b: IO in Low Mutation Burden Cancers Targeted Therapy + Immunotherapy Hall A Clinical
UCSF San Francisco, CA
ucsf.edu Universities & research institutes University of California health sciences campus in San Francisco focused on biomedical research and medicine.	Talk Thu Nov 5 3:10pm–3:25pm Part of Session IV: Emerging Technologies – Incorporation into Clinical Trials In vivo and Solid Tumor CAR-T Cell Therapies Valley of the Sun Ballroom Cell therapy Talk Fri Nov 6 2:10pm–2:30pm Part of Session 106d: Mechanisms of irAEs Unlocking the Specificity of the Autoimmune Response in iRAE’s Hall A Clinical Session Fri Nov 6 3:55pm–5:30pm Immuno-oncology at Immune-privileged Sites Hall A Tumor biology 4:00pm–4:20pmThe Brain Is Not Immune to ImmunityUCSF 4:20pm–4:40pmThe Immune Tumor Microenvironment in Liver CancerNational Institutes of Health 4:40pm–5:00pmThe Privilege of Ocular ImmunityUniversity of Colorado 5:00pm–5:30pm2 abstract presentations — titles not yet released Talk Fri Nov 6 4:00pm–4:20pm Part of Session 107a: Immuno-oncology at Immune-privileged Sites The Brain Is Not Immune to Immunity Hall A Tumor biology Session Sat Nov 7 5:20pm–6:40pm Cellular Therapies Halls BC Cell therapy 5:25pm–5:40pmGenetic, Structural, Chemical and In Situ Engineering of Cell TherapyYale School of Medicine 5:40pm–5:55pmLearnings From a CAR-T Driver Into Solid TumorMassachusetts General Hospital 5:55pm–6:10pmEx Vivo and In Vivo Genome Editing to Reprogram T Cell FunctionUCSF 6:10pm–6:25pmAbstract presentation — title not yet released Talk Sat Nov 7 5:55pm–6:10pm Part of Session 207d: Cellular Therapies Ex Vivo and In Vivo Genome Editing to Reprogram T Cell Function Halls BC Cell therapy